Sandhusker
Well-known member
I wonder if this was discussed at the secret meeting between big pharma and Obama? Do you know, Reader?
reader (the Second) said:It's just business. They spent money developing the drug so they had to spend a lot of money marketing it once they had been beat to the punch by other drugs. This is how big business works, like it or not. The problem is that the U.S. has allowed the pharmaceutical industry too much leeway in advertising and marketing.
reader (the Second) said:Different drugs affect different people so it makes sense to have several. The point is the market was saturated so they had to find a way to still make money off of Lexpro.
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, Andrea Cipriani, Toshiaki A Furukawa, Georgia Salanti, John R Geddes, et al. The Lancet , Published Online, January 29, 2009, DOI:10.1016/S0140-6736(09)60046-5
reader (the Second) said:It's just business. They spent money developing the drug so they had to spend a lot of money marketing it once they had been beat to the punch by other drugs. This is how big business works, like it or not. The problem is that the U.S. has allowed the pharmaceutical industry too much leeway in advertising and marketing.
reader (the Second) said:Steve, regardless of the specifics of Lexpro, do you approve of this marketing plan?
Under “Rep Promotional Programs,” the document said the company planned to spend $34.7 million to pay 2,000 psychiatrists and primary care doctors to deliver 15,000 marketing lectures to their peers in one year.
“These meetings may be large-scale dinner programs with a slide presentation, small roundtable discussions or one-on-one advocate lunches,” the document states.
Under “Lunch and Learns,” the company intended to spend $36 million providing lunch to doctors in their offices. “Providing lunch for a physician creates an extended amount of selling time for representatives,” the document states.
An entire section of the marketing plan, titled “Continuing Medical Education,” outlines how the company intended to use educational seminars for doctors to teach them about Lexapro. The Senate’s Special Committee on Aging held a hearing in July on whether industry funding of medical education classes leads to tainted talks.
Oldtimer said:reader (the Second) said:Steve, regardless of the specifics of Lexpro, do you approve of this marketing plan?
Under “Rep Promotional Programs,” the document said the company planned to spend $34.7 million to pay 2,000 psychiatrists and primary care doctors to deliver 15,000 marketing lectures to their peers in one year.
“These meetings may be large-scale dinner programs with a slide presentation, small roundtable discussions or one-on-one advocate lunches,” the document states.
Under “Lunch and Learns,” the company intended to spend $36 million providing lunch to doctors in their offices. “Providing lunch for a physician creates an extended amount of selling time for representatives,” the document states.
An entire section of the marketing plan, titled “Continuing Medical Education,” outlines how the company intended to use educational seminars for doctors to teach them about Lexapro. The Senate’s Special Committee on Aging held a hearing in July on whether industry funding of medical education classes leads to tainted talks.
It turns Doctors into paid shills (whores) of the Pharmaceutical industry to pimp their new more expensive products to the consumers/patients....Which in turn runs up medical costs which then in turn runs up insurance bills- and ultimately insurance premiums that Joe Blow on the street has to pay....
Same thing is happening in the Veterinary field where they have a new miracle drug every year that the Vets promote (depending on which Pharma company they shill for)-- and each Pharma company has a new vaccination program every year....
Pretty soon the Vets will be advising vaccinating to prevent the vaccination :roll:
http://en.wikipedia.org/wiki/Medicinal_leechesannelids comprising the subclass Hirudinea,.. but most commonly Hirudo medicinalis
reader (the Second) said:Timely news.
Pfizer agrees record fraud fine
US drugmaker Pfizer has agreed to pay $2.3bn (£1.4bn) in the largest healthcare fraud settlement in the history of the Department of Justice.
Pfizer pleaded guilty to a criminal violation of the Food, Drug and Cosmetic Act for misbranding drugs.
It illegally promoted four drugs and caused false claims to be submitted to government healthcare programmes for uses that were not medically accepted.
US officials said Pfizer would have to enter a corporate integrity agreement.
The pharmaceutical firm said earlier this year that it would pay the fine "to put issues that diminish trust behind us".
Pfizer reported a 90% drop in profit to $268m in the fourth quarter of 2008, because of the $2.3bn legal settlement, indicating that the company was aware they would be paying this sum before the terms of the deal with the Department of Justice were announced.
The company faces a criminal fine of $1.195bn and a subsidiary company of Pfizer - Pharmacia & Upjohn - will forfeit $105m, totalling a criminal resolution of $1.3bn.
The remaining $1bn fine was levied to resolve the allegations under the civil False Claims Act.
Oldtimer said:reader (the Second) said:Steve, regardless of the specifics of Lexpro, do you approve of this marketing plan?
Under “Rep Promotional Programs,” the document said the company planned to spend $34.7 million to pay 2,000 psychiatrists and primary care doctors to deliver 15,000 marketing lectures to their peers in one year.
“These meetings may be large-scale dinner programs with a slide presentation, small roundtable discussions or one-on-one advocate lunches,” the document states.
Under “Lunch and Learns,” the company intended to spend $36 million providing lunch to doctors in their offices. “Providing lunch for a physician creates an extended amount of selling time for representatives,” the document states.
An entire section of the marketing plan, titled “Continuing Medical Education,” outlines how the company intended to use educational seminars for doctors to teach them about Lexapro. The Senate’s Special Committee on Aging held a hearing in July on whether industry funding of medical education classes leads to tainted talks.
It turns Doctors into paid shills (whores) of the Pharmaceutical industry to pimp their new more expensive products to the consumers/patients....Which in turn runs up medical costs which then in turn runs up insurance bills- and ultimately insurance premiums that Joe Blow on the street has to pay....
Same thing is happening in the Veterinary field where they have a new miracle drug every year that the Vets promote (depending on which Pharma company they shill for)-- and each Pharma company has a new vaccination program every year....
Pretty soon the Vets will be advising vaccinating to prevent the vaccination :roll: